3-deazaadenosine has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayton, SJ; Montgomery, JA; Secrist, JA | 1 |
| Chiang, PK; Cory, JG; De Clercq, E; Kim, IK; Olsson, RA; Schneller, SW; Thompson, RD | 1 |
2 other study(ies) available for 3-deazaadenosine and Leukemia L 1210
| Article | Year |
|---|---|
(+/-)-3-(4-Amino-1H-pyrrolo[2,3-d]pyrimidin-1-yl)-5-(hydroxymethyl)- (1 alpha,2 alpha,3 beta,5 beta)-1,2-cyclopentanediol, the carbocyclic analogue of tubercidin.
Topics: Animals; Antineoplastic Agents; Antiviral Agents; Carcinoma, Squamous Cell; Cell Line; Humans; Indicators and Reagents; Laryngeal Neoplasms; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Ribonucleosides; Structure-Activity Relationship; Tubercidin | 1984 |
Biological activity and a modified synthesis of 8-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycin.
Topics: Adenosine Deaminase; Adenosylhomocysteinase; Animals; Antibiotics, Antineoplastic; Cell Division; Dogs; Formycins; Hydrolases; Isomerism; Leukemia L1210; Mice; Pyrazines; Triazoles; Vasodilation | 1984 |